6461 - 6470 of 9140 Results
Title
Year
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study2018RESTRICTEDTitle: Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 165End Page: 176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30391-0Citation Count: 109
-
OPENTitle: Distal Covalent Targeting Suppresses Signaling of Oncogenic K-Ras(G13C) in Cancer CellsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 20Issue #: 7Start Page: 1696End Page: 1706Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.5c00249Best OA location URL: https://doi.org/10.1021/acschembio.5c00249Citation Count: 3
-
OPENTitle: l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 37
- α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders2021OPENTitle: α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance DisordersJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: 1Start Page: 130End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26102Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26102Citation Count: 25
- Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial2015OPENTitle: Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 595End Page: 605Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00008-3Citation Count: 186
-
OPENTitle: Variant-to-function dissection of the 17q21.31 locus resolves ANKRD1 as a convergent regulatory targetJournal Name: BMC Medical GenomicsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12920-026-02375-wBest OA location URL: https://doi.org/10.1186/s12920-026-02375-wCitation Count: 0
- What Parkinson's disease patients say in their own words about their mood and anxiety symptoms2024RESTRICTEDTitle: What Parkinson's disease patients say in their own words about their mood and anxiety symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 130Issue #:Start Page: 107190End Page: 107190Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107190Citation Count: 3
-
OPENTitle: A sensitive assay reveals structural requirements for α-synuclein fibril growthJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 292Issue #: 22Start Page: 9034End Page: 9050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m116.767053Best OA location URL: http://www.jbc.org/article/S0021925820427061/pdfCitation Count: 30
-
OPENTitle: Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in VitroJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 3Issue #: 4Start Page: 4486End Page: 4493Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acsomega.7b01897Best OA location URL: https://doi.org/10.1021/acsomega.7b01897Citation Count: 41
-
OPENTitle: Cortical disinhibition in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3408End Page: 3421Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa274Best OA location URL: https://academic.oup.com/brain/article-pdf/143/11/3408/36134872/awaa274.pdfCitation Count: 83